메뉴 건너뛰기




Volumn 101, Issue 2, 2016, Pages 461-469

Mortality in individuals treated with glucose-lowering agents: A large, controlled cohort study

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METFORMIN; SULFONYLUREA; ANTIDIABETIC AGENT; SULFONYLUREA DERIVATIVE;

EID: 84959370005     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2015-3184     Document Type: Article
Times cited : (23)

References (32)
  • 1
    • 33745863033 scopus 로고    scopus 로고
    • Islet cell failure in type 2 diabetes
    • Prentki M, Nolan CJ. Islet cell failure in type 2 diabetes. J Clin Invest. 2006;116(7):1802-1812.
    • (2006) J Clin Invest , vol.116 , Issue.7 , pp. 1802-1812
    • Prentki, M.1    Nolan, C.J.2
  • 2
    • 0032511583 scopus 로고    scopus 로고
    • Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
    • UK Prospective Diabetes Study (UKPDS) Group
    • Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352(9131):837-853.
    • (1998) Lancet , vol.352 , Issue.9131 , pp. 837-853
  • 3
    • 0032511566 scopus 로고    scopus 로고
    • Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
    • UK Prospective Diabetes Study (UKPDS) Group
    • Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998; 352(9131):854-865.
    • (1998) Lancet , vol.352 , Issue.9131 , pp. 854-865
  • 4
    • 84868652782 scopus 로고    scopus 로고
    • Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: A cohort study
    • Roumie CL, Hung AM, Greevy RA, et al. Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study. Ann Intern Med. 2012;157(9):601-610.
    • (2012) Ann Intern Med , vol.157 , Issue.9 , pp. 601-610
    • Roumie, C.L.1    Hung, A.M.2    Greevy, R.A.3
  • 5
    • 84873656406 scopus 로고    scopus 로고
    • Mortality and other important diabetes-related outcomes with insulin vs other antihyperglycemic therapies in type 2 diabetes
    • Currie CJ, PooleCD,EvansM,Peters JR,MorganCL. Mortality and other important diabetes-related outcomes with insulin vs other antihyperglycemic therapies in type 2 diabetes. J Clin Endocrinol Metab. 2013;98(2):668-677.
    • (2013) J Clin Endocrinol Metab , vol.98 , Issue.2 , pp. 668-677
    • Currie, C.J.1    Poole, C.D.2    Evans, M.3    Peters, J.R.4    Morgan, C.L.5
  • 6
    • 0038279359 scopus 로고    scopus 로고
    • Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes
    • Johnson JA, Majumdar SR, Simpson SH, Toth EL. Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes. Diabetes Care. 2002; 25(12):2244-2248.
    • (2002) Diabetes Care , vol.25 , Issue.12 , pp. 2244-2248
    • Johnson, J.A.1    Majumdar, S.R.2    Simpson, S.H.3    Toth, E.L.4
  • 7
    • 84912100243 scopus 로고    scopus 로고
    • Association between first-line monotherapy with sulphonylurea versus metformin and risk of all-cause mortality and cardiovascular events: A retrospective, observational study
    • Morgan CL, Mukherjee J, Jenkins-Jones S, Holden SE, Currie CJ. Association between first-line monotherapy with sulphonylurea versus metformin and risk of all-cause mortality and cardiovascular events: a retrospective, observational study. Diabetes Obes Metab. 2014;16(10):957-962.
    • (2014) Diabetes Obes Metab , vol.16 , Issue.10 , pp. 957-962
    • Morgan, C.L.1    Mukherjee, J.2    Jenkins-Jones, S.3    Holden, S.E.4    Currie, C.J.5
  • 8
    • 84860117993 scopus 로고    scopus 로고
    • Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: Retrospective cohort study using UK general practice research database
    • Tzoulaki I, Molokhia M, Curcin V, et al. Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database. BMJ. 2009;339:b4731.
    • (2009) BMJ , vol.339 , pp. b4731
    • Tzoulaki, I.1    Molokhia, M.2    Curcin, V.3
  • 9
    • 84914165449 scopus 로고    scopus 로고
    • Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls
    • Bannister CA, Holden SE, Jenkins-Jones S, et al. Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls. Diabetes Obes Metab. 2014;16(11):1165-1173.
    • (2014) Diabetes Obes Metab , vol.16 , Issue.11 , pp. 1165-1173
    • Bannister, C.A.1    Holden, S.E.2    Jenkins-Jones, S.3
  • 10
    • 84871237743 scopus 로고    scopus 로고
    • World Health Organization. Oslo:WHOCollaborating Centre for Drug Statistics Methodology
    • World Health Organization. Guidelines for ATC Classification and DDDAssignment. Oslo:WHOCollaborating Centre for Drug Statistics Methodology; 2015.
    • (2015) Guidelines for ATC Classification and DDDAssignment
  • 11
    • 84959424020 scopus 로고    scopus 로고
    • Lash. Modern Epidemiology. Lippincott Williams, Wilkins; Philadelphia, PA:
    • Kenneth J. Rothman SG, Timothy L. Lash. Modern Epidemiology. Lippincott Williams, Wilkins; Philadelphia, PA: 2008.
    • (2008) Rothman SG, Timothy L
    • Kenneth, J.1
  • 12
    • 44049108508 scopus 로고    scopus 로고
    • The secret of immortal time bias in epidemiologic studies
    • Shariff SZ, Cuerden MS, Jain AK, Garg AX. The secret of immortal time bias in epidemiologic studies. J Am Soc Nephrol. 2008;19(5): 841-843.
    • (2008) J Am Soc Nephrol , vol.19 , Issue.5 , pp. 841-843
    • Shariff, S.Z.1    Cuerden, M.S.2    Jain, A.K.3    Garg, A.X.4
  • 13
    • 85088938629 scopus 로고    scopus 로고
    • The Statistical Analysis of Failure Time Data. John Wiley, Sons; Hoboken, NJ:
    • John D. Kalbfleisch RLP. The Statistical Analysis of Failure Time Data. John Wiley, Sons; Hoboken, NJ: 2011.
    • (2011) Kalbfleisch RLP
    • John, D.1
  • 14
    • 70449647008 scopus 로고
    • Proportional hazards tests and diagnostics based on weighted residuals
    • Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81(3): 515-526.
    • (1994) Biometrika , vol.81 , Issue.3 , pp. 515-526
    • Grambsch, P.M.1    Therneau, T.M.2
  • 15
    • 79961135005 scopus 로고    scopus 로고
    • R Development Core Team.. Vienna: the R Foundation for Statistical Computing
    • R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna: the R Foundation for Statistical Computing. 2011. http://www. R-project. org/.
    • (2011) R: A Language and Environment for Statistical Computing
  • 17
    • 77749296886 scopus 로고    scopus 로고
    • Wickham, Hadley.. 2010 edition. Springer-Verlag; New York, NY 1st Ed. Corrected 3rd Printing
    • Wickham, Hadley. ggplot2: Elegant Graphics for Data Analysis. 1st ed. Corrected 3rd printing. 2010 edition. Springer-Verlag; New York, NY: 2009.
    • (2009) Ggplot2: Elegant Graphics for Data Analysis
  • 18
    • 77950874655 scopus 로고    scopus 로고
    • Combination therapy with sulfonylureas and metformin and the prevention of death in type 2 diabetes: A nested case-control study
    • Azoulay L, Schneider-Lindner V, Dell'aniello S, Schiffrin A, Suissa S. Combination therapy with sulfonylureas and metformin and the prevention of death in type 2 diabetes: a nested case-control study. Pharmacoepidemiol Drug Saf. 2010;19(4):335-342.
    • (2010) Pharmacoepidemiol Drug Saf , vol.19 , Issue.4 , pp. 335-342
    • Azoulay, L.1    Schneider-Lindner, V.2    Dell'Aniello, S.3    Schiffrin, A.4    Suissa, S.5
  • 19
    • 84895816458 scopus 로고    scopus 로고
    • Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus
    • Hemmingsen B, Lund SS, Gluud C, et al. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus. Cochrane Database Syst Rev. 2013;11: CD008143.
    • (2013) Cochrane Database Syst Rev , vol.11 , pp. CD008143
    • Hemmingsen, B.1    Lund, S.S.2    Gluud, C.3
  • 20
    • 34447117471 scopus 로고    scopus 로고
    • Impact of oral antihyperglycemic therapy on all-cause mortality among patients with diabetes in the Veterans Health Administration
    • Kahler KH, Rajan M, Rhoads GG, et al. Impact of oral antihyperglycemic therapy on all-cause mortality among patients with diabetes in the Veterans Health Administration. Diabetes Care. 2007; 30(7):1689-1693.
    • (2007) Diabetes Care , vol.30 , Issue.7 , pp. 1689-1693
    • Kahler, K.H.1    Rajan, M.2    Rhoads, G.G.3
  • 21
    • 84864270406 scopus 로고    scopus 로고
    • Basal insulin and cardiovascular and other outcomes in dysglycemia
    • ORIGIN Trial Investigators
    • ORIGIN Trial Investigators, Gerstein HC, Bosch J, et al. Basal insulin and cardiovascular and other outcomes in dysglycemia. NEngl J Med. 2012;367(4):319-328.
    • (2012) NEngl J Med , vol.367 , Issue.4 , pp. 319-328
    • Gerstein, H.C.1    Bosch, J.2
  • 22
    • 79958197888 scopus 로고    scopus 로고
    • Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: A nationwide study
    • Schramm TK, Gislason GH, Vaag A, et al. Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study. Eur Heart J. 2011; 32(15):1900-1908.
    • (2011) Eur Heart J , vol.32 , Issue.15 , pp. 1900-1908
    • Schramm, T.K.1    Gislason, G.H.2    Vaag, A.3
  • 23
    • 84881567755 scopus 로고    scopus 로고
    • Mortality among veterans with type 2 diabetes initiating metformin, sulfonylurea or rosiglitazone monotherapy
    • Wheeler S, Moore K, Forsberg CW, et al. Mortality among veterans with type 2 diabetes initiating metformin, sulfonylurea or rosiglitazone monotherapy. Diabetologia. 2013;56(9):1934-1943.
    • (2013) Diabetologia , vol.56 , Issue.9 , pp. 1934-1943
    • Wheeler, S.1    Moore, K.2    Forsberg, C.W.3
  • 25
    • 79955466395 scopus 로고    scopus 로고
    • Lipid control in patients with diabetes mellitus
    • Betteridge DJ. Lipid control in patients with diabetes mellitus. Nat Rev Cardiol. 2011;8(5):278-290.
    • (2011) Nat Rev Cardiol , vol.8 , Issue.5 , pp. 278-290
    • Betteridge, D.J.1
  • 26
    • 4344683381 scopus 로고    scopus 로고
    • Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): Multicentre randomised placebo-controlled trial
    • ColhounHM,Betteridge DJ, Durrington PN, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet. 2004;364(9435):685-696.
    • (2004) Lancet , vol.364 , Issue.9435 , pp. 685-696
    • Colhoun, H.M.1    Betteridge, D.J.2    Durrington, P.N.3
  • 27
    • 85144841000 scopus 로고
    • Using multivariate matched sampling and regression adjustment to control bias in observational studies
    • Rubin DB. Using multivariate matched sampling and regression adjustment to control bias in observational studies. J Am Stat Assoc. 1979;74(366):318-328.
    • (1979) J Am Stat Assoc , vol.74 , Issue.366 , pp. 318-328
    • Rubin, D.B.1
  • 28
  • 29
    • 0030731208 scopus 로고    scopus 로고
    • ConfounDing and indication for treatment in evaluation of drug treatment for hypertension
    • Grobbee DE, Hoes AW. ConfounDing and indication for treatment in evaluation of drug treatment for hypertension. BMJ. 1997; 315(7116):1151-1154.
    • (1997) BMJ , vol.315 , Issue.7116 , pp. 1151-1154
    • Grobbee, D.E.1    Hoes, A.W.2
  • 30
    • 0033054397 scopus 로고    scopus 로고
    • Assessment and control for confounDing by indication in observational studies
    • Psaty BM, Koepsell TD, Lin D, l. Assessment and control for confounDing by indication in observational studies. J Am Geriatr Soc. 1999;47(6):749-754.
    • (1999) J Am Geriatr Soc , vol.47 , Issue.6 , pp. 749-754
    • Psaty, B.M.1    Koepsell, T.D.2    Lin, D.L.3
  • 31
    • 70649113093 scopus 로고    scopus 로고
    • A most stubborn bias: No adjustment method fully resolves confounDing by indication in observational studies
    • Bosco JL, Silliman RA, Thwin SS, et al. A most stubborn bias: no adjustment method fully resolves confounDing by indication in observational studies. J Clin Epidemiol. 2010;63(1):64-74.
    • (2010) J Clin Epidemiol , vol.63 , Issue.1 , pp. 64-74
    • Bosco, J.L.1    Silliman, R.A.2    Thwin, S.S.3
  • 32
    • 19144368778 scopus 로고    scopus 로고
    • The use of the propensity score for estimating treatment effects: Administrative versus clinical data
    • Austin PC, Mamdani MM, Stukel TA, Anderson GM, Tu JV. The use of the propensity score for estimating treatment effects: administrative versus clinical data. Stat Med. 2005;24(10):1563-1578.
    • (2005) Stat Med , vol.24 , Issue.10 , pp. 1563-1578
    • Austin, P.C.1    Mamdani, M.M.2    Stukel, T.A.3    Anderson, G.M.4    Tu, J.V.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.